SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-008668
Filing Date
2020-01-30
Accepted
2020-01-30 16:03:29
Documents
6
Period of Report
2020-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205897d3_8k.htm 8-K 22675
2 EXHIBIT 1.1 tm205897d3_ex1-1.htm EX-1.1 253207
3 EXHIBIT 5.1 tm205897d3_ex5-1.htm EX-5.1 10849
4 EXHIBIT 99.1 tm205897d3_ex99-1.htm EX-99.1 9125
5 GRAPHIC tm205897d3_ex5-1img001.jpg GRAPHIC 8190
6 GRAPHIC tm205897d3_ex5-1img002.jpg GRAPHIC 5460
  Complete submission text file 0001104659-20-008668.txt   316241
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 20561401
SIC: 2834 Pharmaceutical Preparations